Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Schmeling H
Growth During Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial
Yearbook of Paediatric Endocrinology
Related publications
Neutropenia During Tocilizumab Treatment Is Not Associated With Infection Risk in Systemic or Polyarticular-Course Juvenile Idiopathic Arthritis
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis
Tocilizumab for Juvenile Idiopathic Arthritis: A Single-Center Case Series
Sao Paulo Medical Journal
Medicine
Tocilizumab in Patients With Anti-TNF Refractory Juvenile Idiopathic Arthritis-Associated Uveitis (APTITUDE): A Multicentre, Single-Arm, Phase 2 Trial
Lancet Rheumatology, The
Rheumatology
Allergy
Immunology
Polyarticular Juvenile Idiopathic Arthritis &Ndash; Epidemiology and Management Approaches
Clinical Epidemiology
Epidemiology
Polyarticular Juvenile Idiopathic Arthritis (pJIA): Clinical and Serologic Predictors of Inactive Disease (ID)
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Biological Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis of Polyarticular Course, Enthesitis-Related Arthritis, and Psoriatic Arthritis: A Consensus Statement
Juvenile Idiopathic Arthritis With Rice Bodies in a 2-Year-Old Girl
Journal of Pediatrics
Child Health
Pediatrics
Perinatology
7.4 Improvements in Individual Disease Components Are Sustained With Long-Term Adalimumab Therapy for Polyarticular Juvenile Idiopathic Arthritis
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
